| IV-12 Pavel Balazki Physiologically-based Pharmacokinetics/Pharmacodynamics model of Dapagliflozin, an oral SGLT2 inhibitor Thursday 14:45-16:15 |
| IV-12 Pavel Balazki Physiologically-based Pharmacokinetics/Pharmacodynamics model of Dapagliflozin, an oral SGLT2 inhibitor Thursday 14:45-16:15 |